Systematic reviews and meta-analyses suggest that high-fibre, high-protein diets can improve glycaemic control and support weight management, though it remains unclear how much of this benefit is directly attributable to enhanced GLP-1 secretion versus other mechanisms
These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist, not a GLP-1 RA
Reduced physical activity often accompanies the initial weeks of GLP-1 therapy when gastrointestinal symptoms are most prominent
Post-marketing surveillance and case reports have documented isolated instances of patients reporting muscle pain, cramping, or weakness while taking GLP-1 medications, though establishing a direct causal relationship remains challenging
Cancelling Willow is simple